Patent · US Active

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

US12091407B2 · kind B2 · utility

0Cited by

42References

28Claims

0Family size

Assignee

VTV THERAPEUTICS LLC · US

Inventors

Adnan M. M. Mjalli · Oak Ridge, US
Dharma Rao Polisetti · High Point, US
Jareer Nabeel Kassis · Colfax, US
Matthew J. Kostura · Hillsborough, US
Mustafa Guzel · Jamestown, US
Otis Clinton Attucks · Winston-Salem, US
Robert Carl Andrews · Jamestown, US
Samuel Victory · Oak Ridge, US
Suparna Gupta · Greensboro, US

Key dates

Filing date	Apr 3, 2023
Grant date	Sep 17, 2024
Priority date	—
Expiry date	Apr 3, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted fused imidazole derivatives, methods of their preparation, pharmaceutical compositions comprising a substituted fused imidazole derivative, and methods of use in treating renal diseases are provided. The substituted fused imidazole derivatives may control the activity or the amount or both the activity and the amount of heme-oxygenase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.